Hellen Oduor

Dr. Hellen Oduor

Methodist Dallas Medical Center
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
AMAlejandro Mejia
Alejandro Mejia
SCStephen S. Cheng
Stephen S. Cheng
EVElaina Vivian
Elaina Vivian
JSJimmy Shah
Jimmy Shah
HOHellen Oduor
Hellen Oduor
PAPriyanka Archarya
Priyanka Archarya

27 January 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
RPRachel E. Patzer
Rachel E. Patzer
JSJesse D. Schold
Jesse D. Schold
RHRyutaro Hirose
Ryutaro Hirose
JCJennifer A. Cowger
Jennifer A. Cowger
MUMegan Urbanski
Megan Urbanski
SMSumit Mohan
Sumit Mohan
There is substantial variation in access to transplantation across the United States that is not entirely explained by the availability of donor organs. Barriers to transplantation and variation in care among patients with end-stage organ disease exist prior to patients' placement on a transplant waiting list as well as following waitlist placement. However, there are currently no national data available to examine rates and variations in key care processes related to pre-listing, including transplant referral, evaluation, or candidate selection. In February of 2024, the Health Resources and Services Administration (HRSA) released a directive and, in November 2024, released for public comment the proposed expansion of the Organ Procurement and Transplantation Network (OPTN) data collection to include pre-waitlist data for all solid organ transplant patients to promote transparency across the transplant continuum. While data elements and details have not been finalized, the purpose of this article is to detail the rationale and anticipated details for pre-waitlisting data collection to inform the transplant community. These data aim to examine care processes and barriers to care for patients with end-stage organ disease in the United States.

EVElaina Vivian
Elaina Vivian
HOHellen Oduor
Hellen Oduor
Preeti GirishaPreeti Girisha
Preeti Girisha
PMParvez Mantry
Parvez Mantry
Individuals with chronic medical conditions like cancer often experience heightened stress levels that can impact medical decision-making. The aim of this study was assess the impact of mindful stress-reduction interventions in cancer patients and support group participants (which included current and former cancer patients and their caregivers). A pilot study was conducted in which participants were provided a mindful stress-reduction intervention to determine whether they reduced stress, anxiety, and communication issues. Participants were provided a one-hour mindful stress-reduction intervention by a licensed physical therapist. Surveys were given to participants immediately before and after, and again 7-days after the intervention. Perceived stress was ascertained by asking participants: “Which emotional/mental state do you most frequently find yourself in?” Anxiety and communication abilities were measured using Neuro-QoL™ Anxiety and Communication v.1 instruments. Fifty-nine participants with a mean age of 60.6 years completed the study. Of these, 30.5%, 6.8%, 23.7%, and 39% were diagnosed (or were a caregiver to someone diagnosed) with pancreas, liver, breast, or unknown cancers, respectively. The surveys showed that participants’ perceived stress scores (p < 0.001), anxiety levels (p = 0.0067), and pain scores (p < 0.0001) were reduced after the mindful stress-reduction intervention. Larger studies with control groups are needed to confirm the interventions’ benefits.